Influenza Treatment Regimen
For an otherwise healthy adult with influenza-like illness within 48 hours of symptom onset, start oseltamivir 75 mg orally every 12 hours for 5 days if fever >38°C is present, along with supportive care including rest, hydration, and antipyretics (avoiding aspirin). 1, 2
Antiviral Therapy Decision Algorithm
Criteria for Antiviral Treatment
Antivirals should be initiated if ALL three of the following are present:
- Acute influenza-like illness (fever, cough, myalgias, malaise)
- Fever >38°C
- Symptomatic for ≤48 hours 1, 2
Dosing Regimen
- Oseltamivir 75 mg orally every 12 hours for 5 days 1, 2
- Reduce dose by 50% (75 mg once daily) if creatinine clearance <30 mL/min 1, 2
Important Exceptions
- Immunocompromised or very elderly patients may receive antivirals despite lack of documented fever, as they may not mount adequate febrile response 1, 2
- Severely ill or hospitalized patients may benefit from antivirals started >48 hours after symptom onset, though evidence is limited 1, 2
Antibiotic Management
Do NOT Routinely Prescribe Antibiotics
Previously well adults with acute bronchitis complicating influenza, without pneumonia, do not require antibiotics. 1, 2 This is a critical pitfall—antibiotics are commonly overprescribed in influenza.
When to Consider Antibiotics
Add antibiotics only if:
- Worsening symptoms develop (recrudescent fever or increasing dyspnea) 1, 2
- Lower respiratory features appear in high-risk patients 1, 2
Preferred oral regimen: Co-amoxiclav or tetracycline 1, 2 Alternative: Macrolide (clarithromycin/erythromycin) or respiratory fluoroquinolone (levofloxacin/moxifloxacin) for penicillin-intolerant patients 1, 2
Supportive Care
Symptomatic Management
- Antipyretics for fever control (acetaminophen or ibuprofen; avoid aspirin)
- Adequate hydration and oral fluid intake
- Rest until symptom resolution
- Monitor temperature, respiratory rate, and oxygen saturation 2
Monitoring Parameters
Check for clinical deterioration if any of these develop:
- Temperature >37.8°C
- Heart rate >100/min
- Respiratory rate >24/min
- Systolic blood pressure <90 mmHg
- Oxygen saturation <90%
- Inability to maintain oral intake 2
Evidence Quality and Clinical Context
The guidelines 1, 2 are from 2006-2007 pandemic preparedness documents, but their core recommendations remain valid. More recent evidence 3, 4, 5 confirms that antivirals reduce illness duration by approximately 24 hours and may decrease complications when started within 48 hours. The benefit is most significant in high-risk patients (elderly, immunocompromised, pregnant, chronic disease), while healthy outpatients experience modest clinical benefit 3.
Critical caveat: The 48-hour window is not absolute—severely ill patients may still benefit from later treatment 1, 2. However, for routine outpatient management, the greatest efficacy occurs with treatment initiated within 24 hours of symptom onset 6.
Common Pitfalls to Avoid
- Prescribing antibiotics for uncomplicated influenza—this drives antimicrobial resistance without benefit 1, 2
- Delaying antiviral treatment while awaiting laboratory confirmation in appropriate candidates
- Ignoring treatment in immunocompromised/elderly patients who lack fever 1, 2
- Continuing antibiotics when influenza is confirmed and no bacterial superinfection is present
The regimen prioritizes early antiviral intervention within the therapeutic window, avoids unnecessary antibiotic exposure, and provides clear criteria for escalation if complications develop.